3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
4603
Pancreatic Neoplasms
2843
Carcinoma, Hepatocellular
2479
Stomach Neoplasms
2329
Colonic Neoplasms
1790
Rectal Neoplasms
1719
Esophageal Neoplasms
1376
Liver Neoplasms
920
Neoplasms
915
Breast Neoplasms
839
Neoplasm Metastasis
764
Carcinoma, Non-Small-Cell Lung
705
Cholangiocarcinoma
587
Lung Neoplasms
556
Ovarian Neoplasms
535
Esophageal Squamous Cell Carcinoma
513
Gastrointestinal Neoplasms
495
Melanoma
381
Prostatic Neoplasms
373
Biliary Tract Neoplasms
373
Head and Neck Neoplasms
303
Uterine Cervical Neoplasms
288
Carcinoma, Renal Cell
284
Adenocarcinoma Of Esophagus
273
Squamous Cell Carcinoma of Head and Neck
264
Sarcoma
263
Gastrointestinal Stromal Tumors
252
Endometrial Neoplasms
235
Urinary Bladder Neoplasms
226
Gallbladder Neoplasms
225
Interventions
Atropine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Bradycardia
×
Gastrointestinal
×
Clear all
NCT00575523
2008-01-25
atropinePEI
Medical University of Vienna
Phase 4
Completed
31 enrolled